![](https://imageio.forbes.com/specials-images/imageserve/669e98b34d0e15bdb3196f99/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds)
Despite Gilead’s Promising HIV Prevention Drug, A Vaccine Is Still The ‘Holy Grail’
“Until there’s a cure or a vaccine, we will need to sustain the AIDS response beyond 2030,” UNAIDS Executive Director Winnie Byanyima said last month. AFP via Getty Images When drugmaker Gilead Sciences announced interim late-stage trial results of its …